Fierce Biotech January 5, 2024
Conor Hale

The maker of a wearable garment for tracking heart rate, breathing and physical activity has obtained an FDA clearance for artificial intelligence-powered software that enables continuous monitoring of blood pressure without an inflatable cuff.

Fit snugly across a person’s chest, Nanowear’s SimpleSense wearable is built with cloth-based sensor technology to provide medical-grade remote vital sign tracking, including ECG data and heart sounds.

The new 510(k) green light—marking the company’s fourth—for the SimpleSense-BP program aims to support the at-home diagnosis of hypertension, as well as within healthcare facilities or clinical studies. Everyday settings can lead to more accurate readings than under the examination of a physician, where anxiety may raise blood pressure levels while calm, controlled breathing may lower them.

“This...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology, Wearables
Key Benefits of CGM Technology
'We can nip a pandemic in the bud with smartwatches'
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance

Share This Article